Ledger.Open graph →
SEC Form D · filed July 14, 2015

Juno Therapeutics, Inc

Offering
Sold
$849.8M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
SEATTLE, WA
Type

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (29)

Richard J. Klausner · Seattle, WADirector · PromoterHal J. Barron · Seattle, WADirectorRobert J. Nelsen · Seattle, WADirector · PromoterAnthony J. Evnin · Seattle, WADirectorMary A. Wilderotter · Seattle, WADirectorHoward J. Pien · Seattle, WADirectorHyam Levitsky · Seattle, WAExecSteven Harr · Seattle, WAExecMarc J. Tessier-Lavigne · Seattle, WADirectorBernard J. Cassidy · Seattle, WAExecHans Bishop · Seattle, WAExec · Director · PromoterMark Frohlich · Seattle, WAExec · PromoterGordon A. Gardiner · KIRKLAND, WAExecPatricio A. Stocker · Toronto, Ontario, CanadaDirectorScott A. Laitinen · Toronto, Ontario, CanadaDirector · PromoterPaul A. Wyckoff · KIRKLAND, WAExec · PromoterChris A. Mccormack · KIRKLAND, WADirector · PromoterMark J. Knepper · Rancho Santa Fe, CADirectorCarlos Manuel A. Uribe · Toronto, Ontario, CanadaExec · DirectorErnest T. Cummins · Albuquerque, NMExec · Director · PromoterSteven D. Mckean · KIRKLAND, WAExec · Director · PromoterMatthew D. Campbell · Rancho Santa Fe, CAExec · Director · PromoterChristopher A. Hansen · Toronto, Ontario, CanadaDirectorStephan A. Weitz · KIRKLAND, WAExec · DirectorDavid A. Yun · Toronto, Ontario, CanadaExecJulie A. Barbo · KIRKLAND, WADirectorPaul M. Duncan · Arvada, COExec · Director · PromoterRobin Dyche · Albuquerque, NMDirectorSimon A. Langelier · Toronto, Ontario, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗